(Q54703436)

English

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation.

scientific article published in October 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

1 reference

based on heuristic

inferred from title

author name string

Böttcher S

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Ritgen M

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Pott C

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Brüggemann M

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Raff T

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Stilgenbauer S

6

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Döhner H

7

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Dreger P

8

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

Kneba M

9

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

18

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

10

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

1637-1645

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403478

0 references

Genomic aberrations and survival in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Rituximab dose-escalation trial in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

The prognostic impact of autologous stem cell transplantation in patients with chronic lymphocytic leukemia: a risk-matched analysis based on the VH gene mutational status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Stem cell transplantation for chronic lymphocytic leukemia: different outcome after autologous and allogeneic transplantation and correlation with minimal residual disease status.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Assessment of IgH PCR strategies in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Detection of minimal residual disease in acute leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Detection of rare cells at a frequency of one per million by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

Detection of minimal residual disease in B Chronic Lymphocytic Leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

21 January 2018

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Different clinical value of minimal residual disease after autologous and allogeneic stem cell transplantation for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease in B-cell chronic lymphocytic leukaemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft-versus-leukemia activity may overcome therapeutic resistance of chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene status: implications of minimal residual disease measurement with quantitative PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Cell surface CD43 determination improves diagnostic precision in late B-cell diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403478

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403478

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/15343348

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54703436&oldid=1493289394"